Clinical outcome in coronavirus disease patients treated with tocilizumab at a dedicated COVID hospital: A retrospective observational study

Various studies have reported that there has been a decrease in IL-6 level, C-reactive protein (CRP) level, and lower risk of death with the use of tocilizumab in patients with severe COVID-19 disease. [5] Therefore, cytokine storm has an important role in disease progression with the viral invasion...

Ausführliche Beschreibung